mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.047 |
0.4 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.4 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.4 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |